1-4 of 4
Istvan Majer
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Evolving Unmet Need in Patients Refractory to Lenalidomide: Overview of the Clinical Trials in Relapsed/Refractory Multiple Myeloma

Maria-Victoria Mateos, MD PhD, Rohan Medhekar, PhD, Istvan Majer, PhD, Mehmet Turgut, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 22–23.
https://doi.org/10.1182/blood-2020-142642
Published: 2020
Journal Articles

Carfilzomib 56mg/m2 Twice-Weekly in Combination with Dexamethasone and Daratumumab (KdD) Versus Daratumumab in Combination with 8 Cycles of Bortezomib and Dexamethasone (DVd); A Matching-Adjusted Indirect Treatment Comparison

Katja Weisel, MD, Ajay Nooka, MDMPH, Evangelos Terpos, MDPhD, Andrew Spencer, Hartmut Goldschmidt, MD, Istvan Majer, PhD, Lucy DeCosta, MSc, Rohan Medhekar, PhD, Akeem Yusuf, PhD BPharm, Shaji K. Kumar, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 8–9.
https://doi.org/10.1182/blood-2020-141995
Published: 2020
Journal Articles

Estimating Utilities for Panobinostat in Combination with Bortezomib and Dexamethasone Versus Bortezomib and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma; Evidence from the Panorama-1 Trial

Istvan Majer, Arun Krishna, Gijs van de Wetering, Jesús F. San-Miguel, MD PhD, Paul G. Richardson
Journal: Blood
Blood (2015) 126 (23): 4504.
https://doi.org/10.1182/blood.V126.23.4504.4504
Published: 2015
Journal Articles

Efficacy of Treatments in Relapsed or Relapsed and Refractory Multiple Myeloma: An Indirect Treatment Comparison

Paul G. Richardson, Jae Hoon Lee, MD PhD, Istvan Majer, Arun Krishna, Richard C. Woodman, MD
Journal: Blood
Blood (2014) 124 (21): 2638.
https://doi.org/10.1182/blood.V124.21.2638.2638
Published: 2014